{"database": "lobbying", "table": "lobbying_activities", "rows": [[2261408, "8058f3de-b187-44a2-bf72-9b4241adf05c", "Q1", "MR. BRIAN KELLY", 40024191, "INTELLIA THERAPEUTICS", 2019, "first_quarter", "MED", "WHO Gene Editing Summit", "Defense Advanced Research Projects Agency (DARPA),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office", 0, 0, "2019-04-03T12:18:50.910000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2261408"], "units": {}, "query_ms": 1.3933409936726093, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}